Zhang et al. (2014) conducted a study to determine the effect of andrographolide on insulinoma tumor growth. Andrographolide was found to inhibit the progression of insulinoma tumor by targeting the TLR4/NF-κB signaling pathway (Zhang et al., 2014). Here, NFKB1 is linked to neoplasm.